Tailored treatment may be a possibility for AAV in people with GPA or MPA

AAV relapse rates did not significantly differ between individually tailored and fixed schedule rituximab regimens. Introduction Granulomatosis is a medical term for a disease where granulomas – or clusters of certain cell types – are formed. This can happen in immune or inflammatory diseases. People can have with granulomatosis with polyangiitis (also known as Wegener’s […]

Read More…

Newly updated advice on the treatment of patients with AAV

INTRODUCTION A central focus of newly updated recommendations on treating ANCA-associated vasculitis (AAV) is shared decision-making between patients and doctors. The updated recommendations, produced by a collaboration between the European League Against Rheumatism (EULAR) and European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), taking account of recent research on the benefits and safety […]

Read More…